Drugs / LV
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07123441 | Sep 2025 → Sep 2027 expected | colorectal cancer | Sanjun Cai | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | LV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT07123441 ↗ |
| Route | Intravenous | “LV: 400 mg/m², intravenous infusion over 2 hours, Day 1” NCT07123441 ↗ |